Methanol Toxicity

Update Item Information
Identifier lovasz-methanol-toxicity
Title Methanol Toxicity
Creator Daniel Lovasz; James Brian Davis; Amanda Dean Henderson, MD
Affiliation (DL) Neuro-Ophthalmology, Wilmer Eye Institute, Johns Hopkins Medicine; (JBD) Neuro-Ophthalmology, Wilmer Eye Institute, Johns Hopkins Medicine; (ADH) Neuro-Ophthalmology, Wilmer Eye Institute, Johns Hopkins Medicine
Subject Acidosis; Fomepizole; Formic Acid; Methanol Toxicity; Toxic Optic Neuropathy
Description Methanol toxicity can be very dangerous with high morbidity and mortality rates, and outcomes typically worsen with increasing acidemia, hyperglycemia, or acute kidney injury. Delayed treatment can result in irreversible injury, such as vision loss, or even death. The harmful effects of methanol come from its toxic metabolites, formaldehyde, and formic acid, as it is metabolized by alcohol dehydrogenase in the liver. Formic acid itself contributes to an anion-gap metabolic acidosis, but after it is deprotonated, formate also inhibits the cytochrome c oxidase pathway in oxidative phosphorylation, contributing further to acidosis and oxidative damage. This damage leads to methanol-induced toxic optic neuropathy, leukotriene-mediated neuroinflammation, acute kidney injury, and liver damage. Patients may experience CNS and GI effects such as confusion, drowsiness, nausea, vomiting, and abdominal pain in the first 4 hours after methanol poisoning, followed by acute kidney injury and ophthalmic manifestations from 6-24 hours after poisoning. In the neuro-ophthalmology clinic, there are several important clues that could lead to diagnosing methanol-induced toxic optic neuropathy. In the history, a patient may complain of photophobia or vision loss and may have a history of ingestion from a suicide attempt, consumption of homemade alcohol, or accidental poisoning. On examination, they may have several findings including reduced visual acuity, dilated pupils with decreased reactivity to light, nystagmus, normal intraocular pressure, normal anterior segment findings, bilateral optic disc edema, and hyperemia. Visual field testing may show a central or cecocentral scotoma. OCT RNFL testing may show optic nerve edema in the acute phase and thinning later on. OCT ganglion cell analysis may also show atrophy. Neuroimaging may reveal bilateral lesions in the basal ganglia, necrosis of the putamen, or abnormal changes to the caudate nucleus. Patients may develop Parkinsonian symptoms as a result of these types of injuries. Patients with methanol toxicity are treated acutely with ethanol or fomepizole +/- hemodialysis. Ethanol and fomepizole act as competitive inhibitors of alcohol dehydrogenase, thus slowing down the formation of toxic intermediates from methanol metabolism.
Date 2023-07
References [1] Fein DM, Sue YJ. Methanol ingestion. Pediatr Rev. Dec 2011;32(12):549-50. doi:10.1542/pir.32-12-549; [2] Liberski S, Kaluzny BJ, Kocięcki J. Methanol-induced optic neuropathy: a still-present problem. Arch Toxicol. Feb 2022;96(2):431-451. doi:10.1007/s00204-021-03202-0; [3] Md Noor J, Hawari R, Mokhtar MF, et al. Methanol outbreak: a Malaysian tertiary hospital experience. Int J Emerg Med. Feb 7 2020;13(1):6. doi:10.1186/s12245-020-0264-5; [4] Nalcacioglu P, Kavuncu S, Taskin Turkmenoglu T, Sonmez CA. The effect of idebenone and corticosteroid treatment on methanol-induced toxic optic nerve and retinal damage in rats: biochemical and histopathological examination. Cutan Ocul Toxicol. Sep 2022;41(3):250-256. doi:10.1080/15569527.2022.2106994; [5] Nekoukar Z, Zakariaei Z, Taghizadeh F, et al. Methanol poisoning as a new world challenge: A review. Ann Med Surg (Lond). Jun 2021;66:102445. doi:10.1016/j.amsu.2021.102445; [6] Pohanka M. Toxicology and the biological role of methanol and ethanol: Current view. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. Mar 2016;160(1):54-63. doi:10.5507/bp.2015.023; [7] Mathew F, Goyal A. Ethanol. StatPearls. StatPearls Publishing; Copyright © 2023, StatPearls Publishing LLC.; 2023.; [8] McEnery B, Scalzo A, Maliakkal J. Methanol toxicity in a pediatric patient treated with fomepizole and hemodialysis. CEN Case Rep. May 2023;12(2):195-199. doi:10.1007/s13730-022-00744-9; [9] McMartin K, Brent J. Analysis of Fomepizole Elimination in Methanol- and Ethylene Glycol-Poisoned Patients. J Med Toxicol. Jan 2022;18(1):19-29. doi:10.1007/s13181-021-00862-3; [10] Rietjens SJ, de Lange DW, Meulenbelt J. Ethylene glycol or methanol intoxication: which antidote should be used, fomepizole or ethanol? Neth J Med. Feb 2014;72(2):73-9.; [11] Beatty L, Green R, Magee K, Zed P. A systematic review of ethanol and fomepizole use in toxic alcohol ingestions. Emerg Med Int. 2013;2013:638057. doi:10.1155/2013/638057; [12] Mégarbane B. Treatment of patients with ethylene glycol or methanol poisoning: focus on fomepizole. Open Access Emerg Med. 2010;2:67-75. doi:10.2147/oaem.s5346; [13] Ashurst JV, Nappe TM. Methanol Toxicity. StatPearls. StatPearls Publishing; Copyright © 2023, StatPearls Publishing LLC.; 2023.; [14] Jones AW. Clinical and forensic toxicology of methanol. Forensic Sci Rev. Jul 2021;33(2):117-143.; [15] Brent J. Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings. Clin Toxicol (Phila). Jun 2010;48(5):401-6. doi:10.3109/15563650.2010.495347; [16] Wagner FW, Burger AR, Vallee BL. Kinetic properties of human liver alcohol dehydrogenase: oxidation of alcohols by class I isoenzymes. Biochemistry. Apr 12 1983;22(8):1857-63. doi:10.1021/bi00277a018; [17] Ahmadabadi A, M. S, Ranjbar A, Poorolaja lJ, Nasiripour H, Ahmadabadi M. Quantitative analysis and health risk assessment of methanol in medicinal herbal drinks marketed in Hamadan, Iran. Journal of Applied Pharmaceutical Science2016.; [18] Paasma R, Hovda KE, Hassanian-Moghaddam H, et al. Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes--a multicenter study. Clin Toxicol (Phila). Nov 2012;50(9):823-31. doi:10.3109/15563650.2012.728224; [19] Sanaei-Zadeh H, Esfeh SK, Zamani N, Jamshidi F, Shadnia S. Hyperglycemia is a strong prognostic factor of lethality in methanol poisoning. J Med Toxicol. Sep 2011;7(3):189-94. doi:10.1007/s13181-011-0142-x; [20] Sanaei-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol (Phila). Feb 2011;49(2):102-7. doi:10.3109/15563650.2011.556642; [21] Stellpflug SJM, Ellsworth H, Engebrestsen M, et al. A cost comparison of fomepizole and hemodialysis in the treatment of methanol and ethylene glycol toxicity. Clinical Toxicology (Philadelphia, Pa.)2011.; [22] Sharma P, Sharma R. Toxic optic neuropathy. Indian J Ophthalmol. Mar-Apr 2011;59(2):137-41. doi:10.4103/0301-4738.77035; [23] BRUNNER AJ. Delamination Behavior of Composites. Woodhead Publishing; 2008.; [24] Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report. Clin Toxicol (Phila). Dec 2016;54(10):924-1109. doi:10.1080/15563650.2016.1245421; [25] Kraut JA, Mullins ME. Toxic Alcohols. N Engl J Med. Jan 18 2018;378(3):270-280. doi:10.1056/NEJMra1615295; [26] Gallagher N, Edwards FJ. The Diagnosis and Management of Toxic Alcohol Poisoning in the Emergency Department: A Review Article. Adv J Emerg Med. Summer 2019;3(3):e28. doi:10.22114/ajem.v0i0.153; [27] Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med. May 21 2009;360(21):2216-23. doi:10.1056/NEJMct0806112; [28] Kraut JA. Approach to the Treatment of Methanol Intoxication. Am J Kidney Dis. Jul 2016;68(1):161-7. doi:10.1053/j.ajkd.2016.02.058; [29] Karimi S, Arabi A, Shahraki T. Alcohol and the Eye. J Ophthalmic Vis Res. Apr-Jun 2021;16(2):260-270. doi:10.18502/jovr.v16i2.9089; [30] Chang ST, Wang YT, Hou YC, et al. Acute kidney injury and the risk of mortality in patients with methanol intoxication. BMC Nephrol. Jun 6 2019;20(1):205. doi:10.1186/s12882-019-1404-0
Language eng
Format video/mp4
Type Image/MovingImage
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah, 10 N 1900 E SLC, UT 84112-5890
Rights Management Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s62sgp3a
Setname ehsl_novel_novel
ID 2308687
Reference URL https://collections.lib.utah.edu/ark:/87278/s62sgp3a
Back to Search Results